Wellspect HealthCare Establishes Strategic Advisory Board
Wellspect HealthCare has formed a new Strategic Advisory Board to support its growth. The board includes two external advisors with experience in medtech and healthcare leadership.
Mölndal, Sweden – August 07, 2026 – Medical device provider Wellspect HealthCare has established a Strategic Advisory Board to support its next phase of growth. The board will be advised by external experts bringing extensive experience in global medtech, urology, commercial growth, and healthcare leadership.
Wellspect HealthCare, a subsidiary of Dentsply Sirona focused on improving quality of life for individuals with bladder and bowel dysfunction, announced today the appointment of Paul Moraviec and Michael (Mike) Frazzette as external advisors to this board. Their role will be to provide strategic guidance and insights.
Moraviec and Frazzette bring considerable experience from the healthcare sector. Moraviec has held leadership positions in various medical technology companies, particularly in urology and nephrology. Frazzette contributes expertise in commercial development and healthcare markets.
The formation of the advisory board and the addition of these advisors are part of Wellspect HealthCare's strategy to strengthen its global market position and further develop its patient-focused solutions. The company aims to enhance treatment outcomes and quality of life through innovative and user-friendly products.